Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Martek nutraceuticals, supply/service news

MATK issued 341,000 shares to former

Read the full 68 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE